Advances and perspectives on biomarkers

European Thoracic Oncology Platform

Treating peripheral lung tumours with SABR

Diagnosis and treatment in rare cases of thymoma

Treating non-small cell lung cancer with surgery versus SABR

Biomarker analyses in emerging data from PI3K/AKT/mTOR programme clinical trials

Integrating breast cancer genomics and proteomics

Next wave of successful drug therapy strategies in HER2-positive breast cancer

Genetic and clinical factors best for predicting late recurrence in oestrogen receptor positive breast cancer

CD4 T cells in extensively inflitrated breast cancer signal organised immune response and predict survival

How do we design trials that improve outcome?

Breast cancer heterogeneity no barrier to predictive testing